Scholarly Index
Weiqin Li
Nanjing University; 4,846 total citations; 272 total publications; best world rank #45
Nanjing University
4,846Total citations
272Total publications
37H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pancreatitis Pathology and Treatment | Lifetime | 637 | CN 15 | 97.39 |
| Abdominal Surgery and Complications | Lifetime | 200 | CN 4 | 96.48 |
| Appendicitis Diagnosis and Management | Lifetime | 833 | CN 9 | 93.88 |
| Dermatological and COVID-19 studies | Lifetime | 540 | CN 8 | 81.19 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 45 | CN 3 | 98.47 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 455 | CN 51 | 96.53 |
| Lipid metabolism and disorders | 2021-2025 | 89 | CN 12 | 89.89 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 816 | CN 105 | 89.34 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 398 | CN 45 | 88.86 |
| Appendicitis Diagnosis and Management | 2021-2025 | 375 | CN 19 | 84.04 |
| Clinical Nutrition and Gastroenterology | 2021-2025 | 393 | CN 22 | 83.55 |
| Dermatological and COVID-19 studies | 2021-2025 | 160 | CN 2 | 77.87 |
| Abdominal Surgery and Complications | 2021-2025 | 499 | CN 33 | 64.37 |
| Electrolyte and hormonal disorders | 2021-2025 | 933 | CN 46 | 59.90 |
| Renal function and acid-base balance | 2021-2025 | 843 | CN 75 | 51.47 |